Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

RLYB stock hub

Rallybio Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RLYBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

76.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

RLYB

In the news

Latest news · RLYB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-15

P25 -105.6P50 -46.5P75 -3.1

ROIC-32.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RLYB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001739410
Company name	Rallybio Corporation
Country	United States
Country code	US
Cusip	75120L209
Employees	14
Employees Change	-11%
Employees Change Percent	-44
Enterprise value	$21.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-29
Isin	US75120L2097
Last refreshed	2026-05-10
Market cap	$76.1M
Market cap category	Micro-Cap
Price	$14.38
Price currency	USD
Rev Per Employee	61,285.71x
Sector	Healthcare
Sic	2834
Symbol	RLYB
Website	https://www.rallybio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.8%
EV/Sales	25.06x
FCF yield	-39.19%
P/B ratio	1.31x
P/S ratio	88.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-17.5M
Net Income	$-9M
Net Income Growth Quarters	7%
Net Income Growth Years	2%
Pretax Margin	-1,046.39%
Profit Per Employee	$-641,286
ROA	-30.07
Roa5y	-28.66
ROCE	-54.04
ROE	-15.01
Roe5y	-41.36
ROIC	-32.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	498.7%
Cagr3y	-31.65%
EPS Growth Quarters	7
EPS Growth Years	3
Revenue Growth	34.91x
Revenue Growth Q	484.21x
Revenue Growth Quarters	1x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$62.3M
Cash	$54.7M
Current Assets	$61.3M
Current Liabilities	$4.2M
Debt	$176,000
Debt Equity	$0
Equity	$58M
Liabilities	$4.3M
Long Term Assets	$1M
Long Term Liabilities	$82,000
Net Cash	$54.6M
Net Cash By Market Cap	$71.73
Net Cash Growth	-16.52%
Net Debt Equity	$-0.94
Tangible Book Value	$58M
Tangible Book Value Per Share	$10.97
WACC	-1.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.5
Net Working Capital	$2.4M
Quick ratio	12.96
Working Capital	$57M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.42%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	497.97%
200-day SMA	6.1
3Y total return	-68.07%
50-day SMA	9.52
50-day SMA vs 200-day SMA	50over200
All Time High	206.2
All Time High Change	-93.03%
All Time High Date	2021-07-30
All Time Low	1.76
All Time Low Change	716.58%
All Time Low Date	2025-04-08
ATR	0.81
Beta	-1.1
Beta1y	0.94
Beta2y	0.91
Ch YTD	162
High	14.67
High52	15.31
High52 Date	2026-05-05
High52ch	-6.07%
Low	14.1
Low52	2.16
Low52 Date	2025-06-04
Low52ch	565.74%
Ma50ch	51.02%
Premarket Change Percent	-1.02
Premarket Price	$14.51
Premarket Volume	205
Price vs 200-day SMA	135.74%
RSI	86.26
RSI Monthly	50.67
RSI Weekly	78.17
Sharpe ratio	2.01x
Sortino ratio	4.96
Total Return	-3.42%
Tr YTD	162
Tr1m	78.63%
Tr1w	52.82%
Tr3m	202.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-1.2
Operating Income	$-31.4M
Operating margin	-3,655.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,150,933%
Float Percent	59.57%
Shares Insiders	4.16%
Shares Institutions	28.15%
Shares Out	5,289,675
Shares Qo Q	0.9%
Shares Yo Y	3.42%
Short Float	44.62%
Short Ratio	15.3
Short Shares	26.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-35.1M
Average Volume	620,970.7x
Bv Per Share	10.97
Ch1m	78.63
Ch1w	52.82
Ch1y	497.9
Ch3m	202.7
Ch3y	-68.07
Ch6m	187.5
Change	-1.91%
Change From Open	-1.51
Close	14.66
Days Gap	-0.41
Depreciation Amortization	92,000
Dollar Volume	1,284,019
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-31.4M
EBITDA	$-31.3M
EPS	$-1.59
F Score	3
FCF	$-29.8M
FCF EV Yield	-138.63x
FCF Per Share	$-5.64
Financing CF	16,000
Fiscal Year End	December
Founded	2,018
Investing CF	47,268,000
Ipr	10.62
Iprfo	-87.95
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-16
Last Report Date	2025-12-31
Last Split Date	2026-02-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-16
Ma150	6.64
Ma150ch	116.47%
Ma20	10.03
Ma20ch	43.44%
Net CF	17,471,000
Next Earnings Date	2026-05-22
Open	14.6
Optionable	No
Position In Range	49.12
Post Close	14.38
Postmarket Change Percent	0.07
Postmarket Price	$14.39
Ppne	198,000
Pre Close	14.66
Price Date	2026-05-08
Ptbv Ratio	1.31
Relative Volume	0.14x
Revenue	858,000x
SBC By Revenue	619.35x
Share Based Comp	5,314,000
Tr6m	187.46%
Us State	Connecticut
Volume	89,292
Z Score	-4.02

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does RLYB pay a dividend?

Capital-return profile for this ticker.

Performance

RLYB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RLYB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.2%

Float: +59.6% of shares outstanding

Insider ownership

+4.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RLYB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

86.3

Above 70: short-term overbought

Price vs 200-day MA

+135.7%

50/200-day relationship not available

Beta (5Y)

-1.10

Less volatile than the market

Sharpe ratio

2.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RLYB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RLYB stock rating?

Rallybio Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RLYB analysis?

The full report lives at /stocks/RLYB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RLYB?

The latest report frames RLYB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RLYB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.